Eccrine Neoplasm — Trials

Eccrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02978625	Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers	active not recruiting	Phase 2	68	National Cancer Institute (NCI)NIH	1	Aug 13, 2026	clinicaltrials
NCT07301424	Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL	not yet recruiting	Phase 2	80	University of AlbertaOTHER	1	Aug 12, 2026	clinicaltrials
NCT07152041	Newly-diagnosed Pediatric Ph-positive B-ALL Protocol(CAMS-Ph+ B-ALL)	recruiting	Phase 3	150	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	2	Sep 3, 2025	clinicaltrials
NCT05797415

Data updated 23 days agoSource updated Aug 13, 2026source: clinicaltrials